Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of Body Mass Index on Hypertriglyceridemia Associated with Oral Bexarotene Therapy: A Post Hoc Analysis of an Open-Label Comparative Clinical Study of Combined Bexarotene and Phototherapy Versus Bexarotene Monotherapy for Japanese Patients with Cutaneous T-Cell Lymphoma.
Sanagawa A, Hayakawa T, Yamamoto A, Hotta Y, Furukawa-Hibi Y, Morita A. Sanagawa A, et al. Among authors: morita a. Drugs R D. 2024 Jun;24(2):227-238. doi: 10.1007/s40268-024-00465-7. Epub 2024 Jun 13. Drugs R D. 2024. PMID: 38871976 Free PMC article. Clinical Trial.
Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis.
Kido-Nakahara M, Onozuka D, Izuhara K, Saeki H, Nunomura S, Takenaka M, Matsumoto M, Kataoka Y, Fujimoto R, Kaneko S, Morita E, Tanaka A, Saito R, Okano T, Miyagaki T, Aoki N, Nakajima K, Ichiyama S, Tonomura K, Nakagawa Y, Tamagawa-Mineoka R, Masuda K, Takeichi T, Akiyama M, Ishiuji Y, Katsuta M, Kinoshita Y, Tateishi C, Yamamoto A, Morita A, Matsuda-Hirose H, Hatano Y, Kawasaki H, Fukushima-Nomura A, Ohtsuki M, Kamiya K, Kabata Y, Abe R, Mitsui H, Kawamura T, Tsuji G, Furue M, Katoh N, Nakahara T. Kido-Nakahara M, et al. Among authors: morita e, morita a. Allergol Int. 2024 Apr;73(2):332-334. doi: 10.1016/j.alit.2023.12.001. Epub 2023 Dec 27. Allergol Int. 2024. PMID: 38151410 Free article. No abstract available.
Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients.
Tasaki Y, Ito N, Mimura Y, Sugiyama Y, Ogawa R, Shimura T, Nakamura M, Kawakita D, Hamamoto S, Uemura T, Yokota K, Iida M, Odagiri K, Kimura Y, Hotta Y, Komatsu H, Okuda K, Niimi A, Yasui T, Iwasaki S, Morita A, Kataoka H, Takiguchi S, Furukawa-Hibi Y. Tasaki Y, et al. Among authors: morita a. Asia Pac J Clin Oncol. 2024 Aug;20(4):515-521. doi: 10.1111/ajco.14073. Epub 2024 Apr 29. Asia Pac J Clin Oncol. 2024. PMID: 38682421
Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis.
Kido-Nakahara M, Onozuka D, Izuhara K, Saeki H, Nunomura S, Takenaka M, Matsumoto M, Kataoka Y, Fujimoto R, Kaneko S, Morita E, Tanaka A, Hide M, Okano T, Miyagaki T, Aoki N, Nakajima K, Ichiyama S, Tonomura K, Nakagawa Y, Tamagawa-Mineoka R, Masuda K, Takeichi T, Akiyama M, Ishiuji Y, Katsuta M, Kinoshita Y, Tateishi C, Yamamoto A, Morita A, Matsuda-Hirose H, Hatano Y, Kawasaki H, Tanese K, Ohtsuki M, Kamiya K, Kabata Y, Abe R, Mitsui H, Kawamura T, Tsuji G, Furue M, Katoh N, Nakahara T. Kido-Nakahara M, et al. Among authors: morita e, morita a. J Allergy Clin Immunol Glob. 2024 Jul 31;3(4):100317. doi: 10.1016/j.jacig.2024.100317. eCollection 2024 Nov. J Allergy Clin Immunol Glob. 2024. PMID: 39253106 Free PMC article.
Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study.
Manaka K, Sato J, Hikima Y, Horikoshi H, Taguchi M, Morita A, Suga H, Boki H, Fujimura T, Hirai Y, Shimauchi T, Tateishi C, Kiyohara E, Muto I, Nakajima H, Abe R, Fujii K, Nishigori C, Nakano E, Yonekura K, Funakoshi T, Amano M, Miyagaki T, Yamashita R, Sugaya M, Hamada T, Nangaku M, Iiri T, Makita N. Manaka K, et al. Among authors: morita a. Endocr J. 2024 Aug 8;71(8):777-787. doi: 10.1507/endocrj.EJ23-0699. Epub 2024 Jun 5. Endocr J. 2024. PMID: 38839346 Free article.
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
Blauvelt A, Guttman-Yassky E, Lynde C, Khattri S, Schlessinger J, Imafuku S, Tada Y, Morita A, Wiseman M, Kwiek B, Machkova M, Zhang P, Linaberry M, Li J, Zhang S, Franchin G, Charles ED, De Oliveira CHMC, Silverberg JI. Blauvelt A, et al. Among authors: morita a. JAMA Dermatol. 2024 Aug 1;160(8):856-864. doi: 10.1001/jamadermatol.2024.2131. JAMA Dermatol. 2024. PMID: 39018038 Free PMC article. Clinical Trial.
Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: A subset analysis of two phase 3 randomized trials in plaque psoriasis.
Blauvelt A, Rich P, Sofen H, Strober B, Merola JF, Lebwohl M, Morita A, Szepietowski JC, Lambert J, Hippeli L, Colston E, Balagula E, Banerjee S, Thaçi D. Blauvelt A, et al. Among authors: morita a. J Am Acad Dermatol. 2024 Apr;90(4):775-782. doi: 10.1016/j.jaad.2023.11.060. Epub 2023 Dec 18. J Am Acad Dermatol. 2024. PMID: 38122848 Free article. Clinical Trial.
1,638 results